Skip to main content


Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

Synthetic Lethal Screen Identifies NF-κB as a Target for Combination Therapy with Topotecan for patients with Neuroblastoma

  • Patricia S Tsang1,
  • Adam T Cheuk1,
  • Qing-Rong Chen1,
  • Young K Song1,
  • Thomas C Badgett1,
  • Jun S Wei1 and
  • Javed Khan1Email author
BMC Cancer201212:101

DOI: 10.1186/1471-2407-12-101

Received: 19 August 2011

Accepted: 21 March 2012

Published: 21 March 2012

Back to article

Open Peer Review reports

Pre-publication versions of this article and author comments to reviewers are available by contacting

Original Submission
19 Aug 2011 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
31 Oct 2011 Reviewed Reviewer Report - Darran O'Connor
8 Nov 2011 Reviewed Reviewer Report - Kelly Goldsmith
24 Jan 2012 Author responded Author comments - Jun Wei
Resubmission - Version 3
24 Jan 2012 Submitted Manuscript version 3
Resubmission - Version 4
Submitted Manuscript version 4
Resubmission - Version 5
Submitted Manuscript version 5
Resubmission - Version 6
Submitted Manuscript version 6
Resubmission - Version 7
Submitted Manuscript version 7
6 Feb 2012 Reviewed Reviewer Report - Kelly Goldsmith
Resubmission - Version 8
Submitted Manuscript version 8
21 Mar 2012 Editorially accepted
21 Mar 2012 Article published 10.1186/1471-2407-12-101

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting All previous versions of the manuscript and all author responses to the reviewers are also available.

You can find further information about the peer review system here.

Authors’ Affiliations

Oncogenomics Section, Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute